Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008
AUTOR(ES)
Cohen, J. I.
FONTE
Oxford University Press
RESUMO
Background: Recently novel Epstein–Barr virus (EBV) lymphoproliferative diseases (LPDs) have been identified in non-immunocompromised hosts, both in Asia and Western countries. These include aggressive T-cell and NK-cell LPDs often subsumed under the heading of chronic active Epstein–Barr virus (CAEBV) infection and EBV-driven B-cell LPDs mainly affecting the elderly.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2731018Documentos Relacionados
- Epstein-Barr virus-associated thymidine kinase.
- Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome.
- Are natural killer cells the key to treating Epstein-Barr virus–associated lymphoproliferative disorders?
- Immune regulation in Epstein-Barr virus-associated diseases.
- Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia.
